Trioday Tablets

Trioday Tablets, manufactured by Cipla, is an advanced fixed-dose combination antiretroviral medication developed to effectively manage Human Immunodeficiency Virus (HIV-1) infection. Formulated as a convenient once-a-day treatment, each tablet combines three potent antiviral agents: Lamivudine, Tenofovir Disoproxil Fumarate, and Efavirenz. These active ingredients work in harmony to inhibit the reverse transcriptase enzyme, crucial for preventing the virus from replicating and multiplying within the bloodstream. By rigorously suppressing the viral load, Trioday helps stabilize and strengthen the body’s natural immune system, reducing the risk of opportunistic infections and significantly slowing disease progression. This unified approach ensures high patient adherence and minimizes the daily pill burden. Adherence to strict medical supervision and regular clinical tracking is mandatory to monitor renal, hepatic, and overall patient health during therapy.